-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vi4ZQIuGUjCXrGLXjqaGouSuOMdiSR07FIj9VYRFgNVTUskjiuXGrcvxVoBKeP+7 L0MGvI4nIjAcNiIYWixrKw== 0001014108-99-000232.txt : 19991213 0001014108-99-000232.hdr.sgml : 19991213 ACCESSION NUMBER: 0001014108-99-000232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991102 FILED AS OF DATE: 19991210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LABONE INC CENTRAL INDEX KEY: 0000816151 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 480952323 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-15975 FILM NUMBER: 99772934 BUSINESS ADDRESS: STREET 1: 10101 RENNER BLVD CITY: LENEXA STATE: KS ZIP: 66219 BUSINESS PHONE: 9138888397 MAIL ADDRESS: STREET 1: 10101 RENNER BLVD CITY: LENEXA STATE: KS ZIP: 66219 FORMER COMPANY: FORMER CONFORMED NAME: HOME OFFICE REFERENCE LABORATORY INC DATE OF NAME CHANGE: 19940405 COMPANY DATA: COMPANY CONFORMED NAME: GRANT THOMAS W II CENTRAL INDEX KEY: 0001036337 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O LABONE INC STREET 2: 10310 W 84TH TERRACE PO BOX 2035 CITY: LENEXA STATE: KS ZIP: 66214 MAIL ADDRESS: STREET 1: LABONE INC STREET 2: 10310 W 84TH TERRACE PO BOX 2035 CITY: LENEA STATE: KS ZIP: 66214 4 1 FORM 4 / / Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue See Instruction 1(b). U. S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
- --------------------------------------------------------------------------------------------------------------------------- 1. Name and Address of 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person to Reporting Person* Issuer (Check all applicable) LabOne, Inc. X Director __ 10% Owner - ----------------------------------------------------------------------- (Last) (First) (Middle) 3. IRS or Social 4. Statement for X Officer __ Other Security Month/Year (give title (specify below) Number of Reporting below) Grant II, W. Thomas Person (Voluntary) November 1999 Chairman of the Board of Directors, President, Chief Executive Officer and Class C Director. - ------------------------- ------------------------------------------------------------------------- (Street) 5. If Amendment, Date 7. Individual or Joint/Group Filing of Original (Check applicable line) (Month/Year) X Form filed by One Reporting 10101 Renner Boulevard Person ___ Form filed by More than One Reporting Person - --------------------------------------------------------------------------------------------------------------------------- (City) (State) (Zip) Table 1 - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned. Lenexa, Kansas 66219 - --------------------------------------------------------------------------------------------------------------------------- 1. Title of Security 2. Trans- 3. Trans- 4. Securities 5. Amount of 6. Ownership 7. Nature (Instr. 3) action action Acquired (A) Securities Form: of Indirect date: Code or Disposed of (D) Beneficially Direct Beneficial (Instr.8) (Instr. 3, 4 and 5) Owned at (D) or Ownership End of Mth Indirect (Instr. 4) (Month/ (Instr. 3 (I) Day/ and 4) (Instr.4) Year) ------------------------------------ Code V Amount (A) or Price (D) - --------------------------------------------------------------------------------------------------------------------------- Common Stock 11/24/99 S 94,764 D $8.00 12,793 D - --------------------------------------------------------------------------------------------------------------------------- 128,261 I(1) - --------------------------------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------------- * If the Form is filed by more than one Reporting Person, see instruction 4(b)(v). Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Print or Type Responses) PAGE 1 OF 2 PAGES (Table Continued) FORM 4 (continued) Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================================================================== 1.Title of 2.Conver- 3.Trans- 4.Trans- 5.Number 6.Date Exerci- 7.Title and 8.Price 9.Number 10.Owner- 11.Nature Deriva- sion or action action of Deriv- sable and Amount of of of Deri- ship of In- tive Exercise Date Code ative Expiration Underlying Deriva- vative Form of direct Security Price of (Month/ (Instr. Securi- Date (Month/ Securities tive Securi- Deriv- Bene- (Ins. 3) Deriv- Day/ 8) ties Day/Year) (Instr. 3 Security ties Bene- ative ficial ative Year) Acquired and 4) (Instr. ficially Security; Owner- Security (A) or 5) Owned at Direct ship Disposed End of (D) or (Instr. of (D) Month Indirect 4) (Instr. 3, (Instr. (I) 4, and 5) 4) (Instr. 4) --------------------------------------------------- Code V (A) (D) Date Expira- Exer- tion cisable Date ---------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------- ==================================================================================================================================
Explanation of Responses: (1) Includes (a) 35,923 shares of common stock held by Mr. Grant as custodian for his children, (b) 67,500 shares held in a family trust for which Mr. Grant serves as a co-trustee and in that capacity shares voting and investment powers, (c) 22,365 shares of common stock held in an individually directed account under LabOne's 401(k) profit-sharing plan, as to which Mr. Grant has sole investment power only, and (d) 2,473 shares owned by Mr. Grant's wife as to which Mr. Grant disclaims beneficial ownership. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ W. Thomas Grant II by attorney-in-fact Randy Shelton December 10, 1999 - -------------------------------------------------------- ----------------- W. Thomas Grant II by attorney-in-fact Randy Shelton Date Note:File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. -----END PRIVACY-ENHANCED MESSAGE-----